Business Description
Futura Medical PLC
ISIN : GB0033278473
Total Employee Number:
10Description
Futura Medical PLC is engaged in the development and commercialization of sexual health products. Its product Eroxon is a treatment for erectile dysfunction (commercially available in multiple markets), Eroxon Intense (a new line extension in development) and WSD4000 which is in-development female sexual health portfolio. Geographically, the company derives the majority of its revenue from the United Kingdom and the European Union followed by USA and rest of the world.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.54 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -23.81 | |||||
Beneish M-Score | -6.2 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 14.5 | |||||
3-Year EPS without NRI Growth Rate | 9.1 | |||||
3-Year FCF Growth Rate | 9.6 | |||||
3-Year Book Growth Rate | -32.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.21 | |||||
9-Day RSI | 42.16 | |||||
14-Day RSI | 43.86 | |||||
3-1 Month Momentum % | -84 | |||||
6-1 Month Momentum % | -84.62 | |||||
12-1 Month Momentum % | -98.17 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.06 | |||||
Quick Ratio | 2.06 | |||||
Cash Ratio | 1.57 | |||||
Days Inventory | 195.68 | |||||
Days Sales Outstanding | 150.7 | |||||
Days Payable | 759.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -26.4 | |||||
Shareholder Yield % | -129.66 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 73.07 | |||||
Operating Margin % | -297.94 | |||||
Net Margin % | -534.53 | |||||
EBITDA Margin % | -290.75 | |||||
FCF Margin % | -330.19 | |||||
OCF Margin % | -330.19 | |||||
ROE % | -183.69 | |||||
ROA % | -112 | |||||
ROIC % | -137.29 | |||||
3-Year ROIIC % | 300.32 | |||||
ROC (Joel Greenblatt) % | -268.65 | |||||
ROCE % | -95.75 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 11.79 | |||||
PS Ratio | 0.74 | |||||
PB Ratio | 0.74 | |||||
Price-to-Tangible-Book | 0.05 | |||||
EV-to-EBIT | 0.26 | |||||
EV-to-EBITDA | 0.26 | |||||
EV-to-Forward-EBITDA | 12.54 | |||||
EV-to-Revenue | -0.77 | |||||
EV-to-Forward-Revenue | 4.81 | |||||
EV-to-FCF | 0.22 | |||||
Earnings Yield (Greenblatt) % | 382.33 | |||||
FCF Yield % | -268.25 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Futura Medical PLC Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.974 | ||
| EPS (TTM) (€) | -0.033 | ||
| Beta | 43.6879 | ||
| 3-Year Sharpe Ratio | 0.66 | ||
| 3-Year Sortino Ratio | 8.89 | ||
| Volatility % | 2724.91 | ||
| 14-Day RSI | 43.86 | ||
| 14-Day ATR (€) | 0.002083 | ||
| 20-Day SMA (€) | 0.0024 | ||
| 12-1 Month Momentum % | -98.17 | ||
| 52-Week Range (€) | 0.0005 - 0.142 | ||
| Shares Outstanding (Mil) | 581.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Futura Medical PLC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Futura Medical PLC Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2026 | 2026-09-30 08:30 | In 78 days | ||
| Second quarter earnings results for 2026 | 2026-09-30 | In 77 days | ||
| General meeting for 2025 | 2026-06-29 09:00 | 0.00 (+125.00%) | ||
| Annual report for 2025 | 2026-06-04 | 0.01 (+57.14%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-04-29 09:00 | 0.01 (+17.39%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-29 | 0.01 (+17.39%) | ||
| Second quarter earnings conference call for 2025 | 2025-09-30 08:30 | 0.02 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-09-30 | 0.02 (+0.00%) | ||
| General meeting for 2024 | 2025-06-19 10:00 | 0.08 (+3.11%) | ||
| Annual report for 2024 | 2025-05-27 | 0.08 (+0.00%) |
Show
Entries
Futura Medical PLC Frequently Asked Questions
What is Futura Medical PLC(STU:GYX)'s stock price today?
The current price of STU:GYX is €0.00. The 52 week high of STU:GYX is €0.14 and 52 week low is €0.00.
When is next earnings date of Futura Medical PLC(STU:GYX)?
The next earnings date of Futura Medical PLC(STU:GYX) is 2026-09-30 Est..
Does Futura Medical PLC(STU:GYX) pay dividends? If so, how much?
Futura Medical PLC(STU:GYX) does not pay dividend.
Press Release
Articles on Futura Medical PLC
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers